Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients

Molecular Brain Research

Volumn 41, Issue 1-2, 1996, Pages 128-133

  Doré, Sylvain ^a   Krieger, Charles ^b   Kar, Satyabrata ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Amyotrophic lateral sclerosis; Clinical application; Human; Lou Gehrig's disease; Motor neuron; Neurodegeneration; Trophic factor; Type I IGF receptor; Type II IGF receptor

Indexed keywords

INSULIN; INSULIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NERVE DEGENERATION; NEUROTROPISM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINAL CORD; SPINAL CORD DORSAL HORN; SPINAL CORD VENTRAL HORN; THORACIC SPINAL CORD; WHITE MATTER;

LAMIINAE;

EID: 0004532403     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(96)00081-2     Document Type: Article

References (46)

1. Adem A., Ekblom J., Gillberg P.-G. Growth factor receptors in amyotrophic lateral sclerosis. Mol. Neurobiol. 9:1994;225-231.
2. Aebisher P., Salessiotis A.N., Winn S.R. Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps. J. Neurosci. Res. 23:1989;282-289.
3. Allaoua H., Chaudieu I., Krieger C., Boska P., Privat A., Quirion R. Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients. Brain Res. 579:1992;169-172.
4. Ang L.C., Bhaumick B., Munoz D.G., Saas J., Juurlink B.H.J. Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitro. J. Neurol. Sci. 109:1992;168-172.
5. Ang L.C., Bhaumick B., Juurlink B.H.J. Neurite promoting activity of insulin, insulin-like growth factor I and nerve growth factor on spinal motoneurons is astrocyte dependent. Dev. Brain Res. 74:1993;83-88.
6. Appel S.H. Excitotoxic neuronal cell death in amyotrophic lateral sclerosis. Trends Neurosci. 16:1993;3-4.
7. Appel S.H., Smith R.G. Can neurotrophic factors prevent or reverse motoneuron injury in amyotrophic lateral sclerosis. Exp. Neurol. 124:1993;100-102.
8. Arakawa Y., Sendtner M., Thoenen H. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J. Neurosci. 10:1990;3507-3515.
9. Braunstein G., Reviczky A.T. Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 50:1987;792-794.
10. Caroni P., Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J. Cell. Biol. 110:1990;1307-1317.
11. Caroni P., Becker M. The down-regulation of growth-associated proteins in motoneurons at the onset of synapse elimination is controlled by muscle activity and IGF-I. J. Neurosci. 12:1992;3849-3861.
12. Caroni P. Activity-sensitive signals by muscle-derived IGFs in the developing and regenerating neuromuscular system. Ann. NY Acad. Sci. 692:1993;209-222.
13. Caroni P., Schneider C., Kiefer M.C., Zapf J. Role of muscle insulin-like growth factors in nerve sprouting: Suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. J. Cell. Biol. 125:1994;893-902.
14. Carson M.J., Behringer R.R., Brinster R.L., McMorris F.A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron. 10:1993;729-740.
15. Contreras P.C., Steffer C., Yu K., Callison K., Stong D., Vaught J.L. Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice. J. Pharmacol. Exp. Ther. 274:1995;1443-1449.
16. Danielsen N., Pettmann B., Vahlsing H.L., Manthorpe N., Varon S. Fibroblast growth factor effects of peripheral nerve regeneration in a silicone chamber model. J. Neurosci. Res. 20:1988;320-330.
17. Denys E.H., Pelle-Day G., Spencer E.M. Somatomedin-C is not increased in the serum of patients with amyotrophic lateral sclerosis. Muscle Nerve. 11:1988;1000-1001.
18. Eisen A., Krieger C. Pathogenic mechanisms in sporadic amytrophic lateral sclerosis. Can. J. Neurol. Sci. 20:1993;286-296.
19. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger M.G., Dib B., Rouleau G., Julien J.P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 3:1994;1757-1761.
20. Galli C., Meucci O., Scorziello A., Werge T.M., Calissano P., Schettini G. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-I through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J. Neurosci. 15:1995;1172-1179.
21. Gehrmann J., Yao D.-L., Bonetti B., Bondy C.A., Brenner M., Zhou J., Kreutzberg G.W., Webster H.F. Expression of insulin-like growth factor-I and related peptides during motoneuron regeneration. Exp. Neurol. 128:1994;202-210.
22. Glazner G.W., Lupien S., Miller J.A., Ishii D.N. Insulin-like growth factor-II increases the rate of sciatic nerve regeneration in rats. Neuroscience. 54:1993;791-797.
23. Glazner G.W., Morrison A.E., Iishi D.N. Elevated insulin-like growth factor (IGF) gene expression in sciatic nerves during IGF-supported nerve regeneration. Mol. Brain Res. 25:1994;265-272.
24. Hansson H.A., Rozell B., Skottner A. Rapid axoplasmic transport of insulin-like growth factor I in the sciatic nerve of adult rats. Cell. Tissue Res. 247:1987;241-247.
25. Hirano A. Cytopathology of amyotrophic lateral sclerosis. Adv. Neurol. 56:1991;91-101.
26. Ishii D.N. Relationship of insulin-like growth factor II gene expression in muscle to synaptogenesis. Proc. Natl. Acad. Sci. USA. 86:1989;2898-2902.
27. Ishii D.N., Glazner G.W., Pu S.F. Role of insulin-like growth factors in peripheral nerve regeneration. Pharmacol. Ther. 62:1994;125-144.
28. Kanje M., Skottner A., Lundborg G. Effects of growth hormone treatment on the regeneration of rat sciatic nerve. Brain Res. 475:1988;254-258.
29. Kanje M., Skottner A., Lundborg G., Sjoberg J. Does insulin-like growth factor I (IGF-I) trigger the cell body reaction in the rat sciatic nerve. Brain Res. 563:1991;285-287.
30. 125I]insulin receptor binding sites in the rat hippocampal formation. Neuroscience. 55:1993;69-80.
31. Kerkhoff H., Hassan S.M., Troost D., Van Etten R.W., Veldman H., Jennekens F.G.I. Insulin-like and fibroblast growth factors in spinal cords, nerve roots and skeletal muscle of human controls and patients with amyotrophic lateral sclerosis. Acta Neuropathol. 87:1994;411-421.
32. Li L., Oppenheim R.W., Lei M., Houenou L.J. Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J. Neurobiol. 25:1994;759-766.
33. ALS/North America Myotrophin group, Murphy M.F., Felice K., Gawel M., Gelinas D., Kratz R., Lai F., Lange D., Natter H., Rudnicki S. A double-blind, placebo-controlled study of Myotrophin (CEP-151) in the treatment of amyotrophic lateral sclerosis. Am. Neurol. Assoc. Abstr. 38:1995;335.
34. Nachemson A.K., Lundborg G., Hansson H.A. Insulin-like growth factor I promotes nerve regeneration: an experimental study on rat sciatic nerve. Growth Factors. 3:1990;309-314.
35. Nair N.P.V., Doré S., Kar S., Quirion R. Differential alterations of IGF-I, IGF-II and insulin binding sites in the hippocampal formation following systemic injection of kainic acid to newborn rats. Soc. Neurosci. Abstr. 20:1994;934.
36. Near S.L., Whalen L.R., Miller J.A., Ishii D.N. Insulin-like growth factor II stimulates motor nerve regeneration. Proc. Natl. Acad. Sci. USA. 89:1992;11716-11720.
37. Neff N.T., Prevette D., Houenou L.J., Lewis M.E., Glicksman M.A., Yin Q.W., Oppenheim R.W. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J. Neurobiol. 24:1993;1578-1588.
38. Rabizadeh S., Gralla E.B., Borchelt D.R., Gwinn R., Valentine J.S., Sisodia S., Wong P., Lee M., Hahn H., Bredesen D.E. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA. 92:1995;3024-3028.
39. Reinhardt R.R., Bondy C.A. Insulin-like growth factors cross the blood-brain barrier. Endocrinology. 135:1994;1753-1761.
40. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Henati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W.Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
41. Roth G.A., Spada V., Hamill K., Bornstein M.B. Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue. Dev. Brain Res. 88:1995;102-108.
42. Rowland L.P. Amyotrophic lateral sclerosis: human challenge for neuroscience. Proc. Natl. Acad. Sci. USA. 92:1995;1251-1253.
43. Shefner J.M., Tyler H.R., Kranp C. Abnormalities in the sensory action potentials in patients with amyotrophic lateral sclerosis. Muscle Nerve. 14:1991;1242-1246.
44. Shemer J., Raizada M.K., Master B.A., Ota A., LeRoith D. Insulin-like growth factor I receptors in neuronal and glial cells. Characterization and biological effects in primary culture. J. Biol. Chem. 262:1987;7693-7699.
45. Sjoberg J., Kanje M. Insulin-like growth factor (IGF-I) as a stimulator of regeneration in the freeze-injured rat sciatic nerve. Brain Res. 485:1989;102-108.
46. Tsukagoshi H., Yanagisawa N., Oguchi K., Nagashima K., Murakami T. Morphometric quantification of the cervical limb motor cells in controls and in amyotrophic lateral sclerosis. J. Neurol. Sci. 41:1979;287-297.